n/a 3289002Recalls & reported problems
Medtronic Sofamor Danek, Inc. · INSTRUMENT 3289002 BROACH HANDLE · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00885074035994), received between Mar 15, 2017 and Mar 15, 2017 — classified as 1 injury.
The most frequently reported specific device problem is “Disassembly” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Appropriate Device Problem Term/Code Not Available1
- Disassembly1
Patient problems
- Blood Loss1
- Laceration(s)1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMar 15, 2017Disassembly; Appropriate Device Problem Term/Code Not Available; Disassembly; Appropriate Device Problem Term/Code Not Available
IT WAS REPORTED THAT ON: (B)(6) 2016: PATIENT PRESENTED WITH INTERNAL DISRUPTION OF L5/S1 DISK WITH INTRACTABLE PAIN BACK AND BILATERAL LEGS RESPECTIVELY, STATUS POST DISCOGRAPHIC WORKUP. PATIENT UNDERWENT THE FOLLOWING PROCEDURE: ANTERIOR LUMBAR INTERBODY FUSION AT L5-S1 WITH RADICAL DISCECTOMY USING GRAFT SUPERCHARGED WITH RHBMP-2/ACS WITH FLUOROSCOPIC SUPERVISION DURING SAME, AND LEFT INTRA ABDOMINAL ILIAC VEIN REPAIR. PER-OP NOTES: ¿.. I PROCEEDED TO GRAFT THE L5-S1 SPACE WITH RGRAFT AS A CARRIER SUPERCHARGED WITH RHBMP-2/ACS.¿ INTRA-OPERATIVELY,THE HANDLE, WHICH WAS USED TO PLACE THE TEMPLATE, DISLODGED FROM THE TEMPLATE AND HIT THE PATIENT'S ILIAC VEIN, RESULTING IN A LACERATION OF THE ILIAC VEIN. THE HANDLE WAS USED TO PLACE THE TEMPLATE IN THE DISC PLACE, AS A MEASURING DEVICE, PRIOR TO THE INSERTION OF THE PERMANENT CAGE. ALLEGEDLY, "AS A RESULT OF THE LACERATION TO THE ILIAC VEIN, THE PATIENT LOST 4650 CC OF BLOOD BEFORE THE NEUROSURGEON AND A VASCULAR SURGEON IN THE OPERATIVE SUITE WERE ABLE TO REPAIR THE ILIAC VEIN AND STOP THE BLEEDING. BECAUSE OF THIS EVENT, THE CAGE LUMBAR FUSION WAS ABANDONED." REPORTEDLY, "FOLLOWING THE LACERATION OF THE ILIAC VEIN, A VALIANT ATTEM
Patient problems: Blood Loss; Laceration(s)
MAUDE report 6408505 ↗
Other Intervertebral fusion device with bone graft, lumbar devices
- T-PAL 03.812.003Synthes GmbH · Intervertebral fusion device with bone graft, lumbar152 reports
- T-PAL 03.812.004Synthes GmbH · Intervertebral fusion device with bone graft, lumbar120 reports
- Catalyft PL Expandable Interbody System 6068073Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall66 reports
- Catalyft PL Expandable Interbody System 6069076Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall51 reports
- Catalyft PL Expandable Interbody System 6068076Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall46 reports
- EIT TLIF Inserter TFT30101EIT Emerging Implant Technologies GmbH · Intervertebral Fusion Device With Bone Graft, Lumbar88 reports
- T-PAL 03.812.001Synthes GmbH · Intervertebral fusion device with bone graft, lumbar76 reports
- Catalyft PL Expandable Interbody System 6069096Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall25 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page